Hepatitis C-type treatment proved 12 weeks consecutive response
(Dailypharm)
Hepatitis C-type treatment which is in process of development by Abbvie proved 12 weeks of consecutive treatment efficacy.
Abbvie has recently announced the result of 3 phase clinical demonstrat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
